SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-22-013439
Filing Date
2022-05-10
Accepted
2022-05-10 06:10:50
Documents
78
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q auph-20220331.htm   iXBRL 10-Q 960837
2 EX-31.1 auph-2022q1exx311.htm EX-31.1 10968
3 EX-31.2 auph-2022q1exx312.htm EX-31.2 11110
4 EX-32.1 auph-2022q1exx321.htm EX-32.1 5436
5 EX-32.2 auph-2022q1exx322.htm EX-32.2 5444
  Complete submission text file 0001628280-22-013439.txt   5281265

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT auph-20220331.xsd EX-101.SCH 37657
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT auph-20220331_cal.xml EX-101.CAL 64812
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT auph-20220331_def.xml EX-101.DEF 154213
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT auph-20220331_lab.xml EX-101.LAB 496321
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT auph-20220331_pre.xml EX-101.PRE 319654
72 EXTRACTED XBRL INSTANCE DOCUMENT auph-20220331_htm.xml XML 820161
Mailing Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8
Business Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8 250-708-4272
Aurinia Pharmaceuticals Inc. (Filer) CIK: 0001600620 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A0 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36421 | Film No.: 22907225
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences